Proper use of Quinolones for canine colitis ambulatory treatment: literature review and REQUEST guidelines

• Autorzy: Lechowski R. , Cotard J. P. , Boulouis H. J. , Kietzman M. , Farca A. M. , Fontaine J. , Caney S. , Dupree G.
• Języki publikacji: EN

Abstrakty

EN

The literature analysed by REQUEST (REassesing QUinolone European STandard) using inclusion and exclusion criteria allows to make the conclusion that the proper use of fluoroquinolones (FQ) in canine colitis requires rigorously performed qualification to specific antimicrobial treatment. An infectious agent responsive to FQ therapy plays an integral role in the clinical manifestation of canine colitis, especially histiocytic ulcerative colitis (HUC) in young Boxer dogs. This supports the use of FQ in these cases. The Request guidelines for proper use of FQ in canine colitis is established, according to the available literature data.

• Wydawca: -
• Czasopismo: Polish Journal of Veterinary Sciences
• Rocznik: 2013
• Tom: 16
• Numer: 1
• Opis fizyczny: p.193-197,ref.

Twórcy

autor

Lechowski R.

• Faculty o Veterinary Medicine, University of Life Science in Warsaw, Nowoursynowska 166, 02-776 Warsaw, Poland

autor

Cotard J. P.

• Ecole Nationale Veterinaire d’Alort, Paris, France

autor

Boulouis H. J.

• Ecole Nationale Veterinaire d’Alort, Paris, France

autor

Kietzman M.

• Institut fur Pharmacologie, Toxicologie und Pharmazie, Tierartzliche Hochshule, Hannover, Germany

autor

Farca A. M.

• Departement of Animal Pathology, Faculty of Veterinary Medicine, Turin, Italy

autor

Fontaine J.

• Facuulte Veterinaire, Universite de Liege, Belgium

autor

Caney S.

• Vet Professionals Ltd, Midlothian Innovation Centre, Pentlandfield Roslin Midlothian, United Kingdom

autor

Dupree G.

• Klinik fur Kleintierchirurgie, VetMed Universitat Vienne, Austria

Bibliografia

• Cerquetella M, Spaterna A, Laus F, Tesei B, Rossi G, Antonelli E, Villanaci V, Bassotti G (2010) Inflamatory bowel disease in the dog: differences and similarities with human. World J Gastroenterol 16: 1050-1056.
• CravenM , Dogan B, Schukhen A, Volkman M, Chandler A, McDonough PL, Simpson KW (2010) Antimicrobial resistance impact clinical outcome of granulomatous colitis in boxer dogs. Journal of Veterinary Internal Medicine 24: 819-824.
• Craven M, Mansfield CS, Simpson KW (2011) Granulomatous colitis of boxer dogs. Vet Clin North Am Small Anim Pract 41: 433-445.
• Cummings JH, Macfarlane GT, Macfarlane S (2003) Intestinal bacteria and ulcerative colitis Curr Issues Intest Microbiol 4: 9-20.
• Davies DR, O’Hara AJ, Irwin PJ, Guilford WG (2004) Successful management of histiocytic ulcerative colitis with enrofloxacin in two boxer dogs. Aust Vet J 82: 58-61.
• Gaschen FP (2007) Bacteria and the canine and feline gut: the good, the bad and the ugly, The North American Veterinary Conference 419-421.
• German AJ, Hall EJ, Kelly DF, Watson AD, Day MJ (2000) An immunohistochemical study of histiocytic ulcerative colitis in boxer dogs. J Comp Path 122: 163-175.
• Gibson JS, Cobbold RN, Kyaw-Tanner MT, Heisig P, Trott DJ (2010) Fluoroquinolone resistance mechanisms in multidrug-resistant Escherichia coli isolated from extraintestinal infections in dogs. Vet Microbiol 146: 161-166.
• Hansen R, Thompson JM, El-Omar EM, Hold GL (2010) The role of infection in the aetiology of inflamatory bowel disease, J Gastroenterol 45: 266-276.
• Hill FWG, Sulivan ND (1978) Histiocytic ulcerative colitis in a boxer dog. Aust Vet J 54: 447-479.
• Hostutler RA, Luria BJ, Johnson SE, Weisbrode SE, Sherding RG, Jaeger JQ, Guilford WG (2004) Antibiotic-responsive histiocytic ulcerative colitis in 9 dogs. J Vet Inter Med 18: 499-504.
• Mansfielt C.S. James FE., Craven M., Davies DR., O’Hara AJ., Nicholls PK., Dogan B., MacDonough SP., Simpson KW. Remission of histiocytic ulcerative colitis in Boxer dogs correlate with eradication of invasive intramucosal E.col. Journal of Veterinary Internal Medicine 23: 965-969.
• Satrtor RB (2008) Microbial influences in inflamatory bowel disease. Gastroenterology 134: 577-594.
• Simpson KW, Dogan B, Rishniw M, Goldstein RE, Kleasig S, McDonough PL. German AJ, Yates RM, Russel DG, Johnson SE, Berg DE, Harel J. Bruand G. McDonough SP. Schukken YH (2006) Adherent and invasive E. coli is associated with granulomatous colitis in boxer dogs. Infect mmun 74: 4778-4792.
• Stokes JE. Kruger JM. Mullaney T. Holan K. Schall W (2001) Histiocytic ulcerative colitis in three non-boxer dogs. J Am Anim Hosp Assoc 37: 461-465.
• Suchodolski JS (2011) Companion animals symposium: Microbes and gastrointestinal health of dogs and cats. J Anim Sci 89: 1520-1530.
• Tanaka H, Nakayama M, Takase K (2003) Histiocytic ulcerative colitis in a French bulldog. J Vet Med Sci 65: 431-433.
• Van Kruiningen HJ (1995) On use of antibiotics in Crohn’s disease. J Clin Gastroenterol 20: 310-316.
• Van Kruiningen HJ, Civco IC, Cartun RW (2005) The comparative importance of Escherichia coli antigen in granulomatous colitis of boxer dogs. APMIS 113: 420-425.

Uwagi

PL

Rekord w opracowaniu